NLRP3 and Insulin resistance: Furthermore, NLRP3 inflammasome is also activated by ROS due to increased levels of saturated fatty acids and hyperglycemia, subsequently activating caspase-1, resulting in the secretion of IL-1β and IL-18, driving systemic inflammation, impairing pancreatic β-cell function, and inducing insulin resistance [52,54,55].